Moritz Gudenus discusses the initiatives that transformed Bormioli Pharma from a corporate orphan to a leading standalone European manufacturer of plastic and glass pharmaceutical packaging. The sale of Blitz LuxCo Sarl, the holding company of Bormioli Pharma, to Gerresheimer was announced earlier this year and has now closed. It is one of the six realisations Triton has announced across its private equity funds in 2024 so far - representing an aggregate EUR 2.5 billion in value. Bormioli Pharma’s transformation exemplifies Triton’s operational approach to value creation, leveraging West Park’s functional experts across a wide range of areas – including leadership, financing, ESG, and more. Read the full press release here: https://lnkd.in/efdscJ7y Find out more about Triton here: www.triton-partners.com #BuildingBetterBusinesses
Triton Partners’ Post
More Relevant Posts
-
Symrise AG raises the bar with acquisition bid for Swedish Probi AB. Meanwhile, Danish biotech Saniona makes headlines with one of the largest licensing agreements globally this year, securing a significant partnership for its drug candidate SAN711. Read the full newsletter below: https://lnkd.in/dN64m757 Subscribe to our newsletters here: https://lnkd.in/dzK6hgcS
To view or add a comment, sign in
-
𝐒𝐏𝐈𝐌𝐀𝐂𝐎'𝐬 𝐅𝐘𝟐𝟎𝟐𝟑 𝐑𝐞𝐬𝐮𝐥𝐭𝐬: 𝐀 𝐓𝐮𝐫𝐧𝐚𝐫𝐨𝐮𝐧𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐌𝐚𝐤𝐢𝐧𝐠? #SaudiPharma #FinancialAnalysis 𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬 𝐟𝐫𝐨𝐦 𝐒𝐏𝐈𝐌𝐀𝐂𝐎'𝐬 𝐀𝐧𝐧𝐮𝐚𝐥 𝐑𝐞𝐩𝐨𝐫𝐭: 𝐒𝐭𝐫𝐨𝐧𝐠 𝐫𝐞𝐯𝐞𝐧𝐮𝐞 𝐠𝐫𝐨𝐰𝐭𝐡 : A healthy 16.3% revenue jump highlights positive momentum in the Saudi pharmaceutical sector. 𝐈𝐦𝐩𝐫𝐨𝐯𝐞𝐝 𝐏𝐫𝐨𝐟𝐢𝐭𝐚𝐛𝐢𝐥𝐢𝐭𝐲: Gross profit margin rose, operating profit turned positive, and cost management strategies implemented by SPIMACO's leadership team are bearing fruit. Credit to the team for their focus on efficiency! 𝐍𝐞𝐭 𝐋𝐨𝐬𝐬 𝐏𝐞𝐫𝐬𝐢𝐬𝐭𝐬: Although significantly lower, SPIMACO still needs to address the remaining net loss. 𝐅𝐢𝐧𝐚𝐧𝐜𝐞 𝐂𝐨𝐬𝐭𝐬 𝐁𝐢𝐭𝐞: Higher interest rates impacted profitability, highlighting the need for strategic financial management. 𝐌&𝐀 𝐏𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥: Strategic partnerships to address R&D or other weaknesses could further enhance their performance. 𝐌𝐚𝐬𝐬𝐢𝐯𝐞 𝐭𝐮𝐫𝐧𝐚𝐫𝐨𝐮𝐧𝐝 𝐬𝐭𝐨𝐫𝐲, 𝐛𝐮𝐭 𝐰𝐨𝐫𝐤 𝐫𝐞𝐦𝐚𝐢𝐧𝐬. 𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐲𝐨𝐮𝐫 𝐭𝐡𝐨𝐮𝐠𝐡𝐭𝐬 𝐨𝐧 𝐒𝐏𝐈𝐌𝐀𝐂𝐎'𝐬 𝐟𝐮𝐭𝐮𝐫𝐞? #Discussion #Investment Disclaimer : As a student of Corporate Finance and Company Valuation, I'm analyzing SPIMACO's financials. This post reflects my interpretation and is for educational purposes only.
#SPIMACO announces its FY23 results, maintaining its position at the top of the private sector pharma industry. Commenting, CEO Jerome Cabannes said: “SPIMACO is in a strong position to pursue its growth objectives. With a clear strategy in place, we are well-prepared to face potential challenges & seize opportunities.” Read more 🔗 https://bit.ly/3IYDDXw
To view or add a comment, sign in
-
🔴 In a groundbreaking move, Morocco’s Competition Council has greenlit the acquisition of the pharmaceutical giant Afric-Phar by the Sefrioui Group. The deal, valued at a staggering 2 billion dirhams (approximately €182 million), signals a bold leap into the pharmaceutical sector for Sefrioui, a company previously renowned for its real estate and construction material ventures. https://urls.fr/IhSEHC
To view or add a comment, sign in
-
In Gerresheimer Primary Packaging Plastics we are with our latest acquisition looking forward to offering our customers an even broader range of drug containment solutions by adding new products to our portfolio. Our European footprint will be strengthened with additional 5 plants in Germany, France and Italy. We are excited to welcoming our new colleagues and continue to further develop the best product and service offering to our customers. This acquisition further supports our growth objectives and strengthens our global footprint with existing plants in North America, Brazil, India, China and Europe bringing us closer to our customers worldwide.
"Following the successful completion of the acquisition, we can now focus on the integration of Bormioli Pharma into the Gerresheimer Group," explains Dietmar Siemssen, our CEO. "We are convinced that our customers will benefit from the expansion of the product portfolio and new, integrated systems and solutions." We have successfully completed the acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group announced in May 2024. With this acquisition, we strengthen our European footprint with additional production sites and underpin our market position as a leading full-service provider and global partner for the pharma and biotech industries. Link to our press release: https://lnkd.in/gnsCFr7M #innovatingforabetterlife #bormiolipharma #acquisition #pharma #biotech #healthcare #twostoriesonefuture
To view or add a comment, sign in
-
🌟 Exciting News: Gerresheimer & Bormioli Pharma Join Forces! 🌟 We’re thrilled to announce the merger of Gerresheimer AG and Bormioli Pharma, uniting our expertise to revolutionize healthcare and pharma packaging. Together, we’re set to expand our global reach, enhance innovation, and drive sustainable solutions. Stay tuned for this exciting journey! #MergerAnnouncement #HealthcarePackaging #Innovation #Sustainability
"Following the successful completion of the acquisition, we can now focus on the integration of Bormioli Pharma into the Gerresheimer Group," explains Dietmar Siemssen, our CEO. "We are convinced that our customers will benefit from the expansion of the product portfolio and new, integrated systems and solutions." We have successfully completed the acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group announced in May 2024. With this acquisition, we strengthen our European footprint with additional production sites and underpin our market position as a leading full-service provider and global partner for the pharma and biotech industries. Link to our press release: https://lnkd.in/gnsCFr7M #innovatingforabetterlife #bormiolipharma #acquisition #pharma #biotech #healthcare #twostoriesonefuture
To view or add a comment, sign in
-
This week BioPharmaChem Ireland hosted its Supply Chain Forum in the Ibec Cork Office at which our members led discussions on the key #challenges and #opportunities that lie ahead in terms of #resilience and #decoding scope 3 reductions for the sector in terms of managing supply chain product portfolios. BioPharmaChem Ireland thanks our speakers Jim Hackett of BioMarin Pharmaceutical Inc. and Liam Burke Masterson of SkyCell AG for leading discussions on the topics of: 🔹 #supply chain as a driver of #business #growth 🔹 #transformimg #Pharma #Supply Chains for #resilience & CO2 reduction. Key takeaways: ✅ Merit in connecting in-person with our industry peers that operate within the supply chain area of the business. ✅ Appropriate talent in terms of digital maturity skills can act as an enabler in driving business growth. ✅ Need to drive systemic collaboration by propelling value-chain decarbonisation both upstream & downstream. ✅ Aspiration to mobilise & drive the net-zero culture & practices. Read more on BPCI activities here: https://lnkd.in/dBDiNXYY Karina Cassidy Paul Condon
To view or add a comment, sign in
-
"Following the successful completion of the acquisition, we can now focus on the integration of Bormioli Pharma into the Gerresheimer Group," explains Dietmar Siemssen, our CEO. "We are convinced that our customers will benefit from the expansion of the product portfolio and new, integrated systems and solutions." We have successfully completed the acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group announced in May 2024. With this acquisition, we strengthen our European footprint with additional production sites and underpin our market position as a leading full-service provider and global partner for the pharma and biotech industries. Link to our press release: https://lnkd.in/gnsCFr7M #innovatingforabetterlife #bormiolipharma #acquisition #pharma #biotech #healthcare #twostoriesonefuture
To view or add a comment, sign in
-
#Gerresheimer, Exciting news! The successful acquisition of Bormioli Pharma strengthens our position as a leading partner in #India in the pharma and biotech industries, expanding our offerings and delivering even greater value to our customers. 🚀 #Innovation #Growth #PharmaLeadership, #innovatingforabetterlife #medicalsystems #inhaler #autoinjector #pharma #glass #biotech #cosmetics #healthcare #drug #medicines #pharmaceuticalsupplychain #vials #syringe #ampoules #prefillablesyringes #aseptic #sterile #plasticpackaging #medicaldevices #pharmapackaging #injectables #biosimilars #packaging #OphthalmicDrugsMarket #OphthalmicDrugs #cosmetics #fragrance #personalcare
"Following the successful completion of the acquisition, we can now focus on the integration of Bormioli Pharma into the Gerresheimer Group," explains Dietmar Siemssen, our CEO. "We are convinced that our customers will benefit from the expansion of the product portfolio and new, integrated systems and solutions." We have successfully completed the acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group announced in May 2024. With this acquisition, we strengthen our European footprint with additional production sites and underpin our market position as a leading full-service provider and global partner for the pharma and biotech industries. Link to our press release: https://lnkd.in/gnsCFr7M #innovatingforabetterlife #bormiolipharma #acquisition #pharma #biotech #healthcare #twostoriesonefuture
To view or add a comment, sign in
-
Exciting Moments from Rijeka! 🇭🇷 Check out this short video capturing the highlights of our recent partner meeting in Rijeka. From insightful discussions to a fascinating walking tour of the city, and an inspiring visit to JGL pharmaceutical company - a shining example of corporate social responsibility and sustainability. 📹 Credit: Maura Carty #SIMprojectEU #SocialImpactManager #CorporateSocialResponsibility
To view or add a comment, sign in
-
Van Lanschot Kempen is pleased to announce that it acted as Financial Adviser in connection to NewAmsterdam Pharma Corporation's USD 479 million US Public Offering, which was launched on the back of positive topline data from the pivotal phase 3 BROADWAY trial For more information, please see: https://lnkd.in/eDUS7_jC Or contact Jan De Kerpel or Robin van Wijk
To view or add a comment, sign in
62,925 followers
Business Manager @ Gantrade Europe BVBA | Petrochemicals | Business Development, Strategy | MBA
2wCongratulations! Well done